Farmas USA

Debe de ser el mismo perfil de inversor de riesgo en busca de volatilidad.

Me aburria y me compre unas Arnas...a ver que tal,visto mi exito con yahoo....la bajo de los 4 pavos fijo...

leyendo por foros, no solo small pharmas venden...

esas no resucitan ni con viagra.

paquetón nvax verde

-12% DESDE MAXIMOS DE HOY... ESTAMOS DE COÑA?????????? HdP.....

ARNA

OXGN

$heff entra y parece interesante

[b]New Economy Portfolio[/b]..buying a full position in a stock that will do well into their Nov 9th Catalyst date.

[b]Alert bought full position $OXGN at $2.15 in the New Economy Portfolio[/b]..Gynecologic Oncology Group (GOG) Ph.2 Ovarian Cancer Trial data will be presented in Oct./Nov timeframe from late Sept meeting that I had earlier.

The company has a market cap of only 39m. It has an O/S of 15.3m and a float of 13.4m. Company just did a recent financing at $2.96/share. OXGN has a 52wk low of $1.96 & a 52wk high of $5.40.
Oxigene Corporate Presentation May 2014..$OXGN http://bit.ly/1jfm32B

OXGN..Wainright assumes a buy on 6/26/14. http://www.smarteranalyst.com/2014/06/26/h-c-wainright-assumes-buy-as-oxigene-displays-tremendous-potential-upside/

OXiGENE, Inc. Announces $16 Million At-The-Market Registered Direct Offering. This offering was done at $2.96/share.
http://finance.yahoo.com/news/oxigene-inc-announces-16-million-130000685.html

@adamfeuerstein: $OXGN Surprises With Positive Ovarian Cancer Study Success —> http://t.co/67O3wta2B4

@FierceBiotech: Oxigene roars back to life on positive ovarian cancer study. http://t.co/fI9oX3ItGX

http://investorshub.advfn.com/boards/post_reply.aspx?message_id=104080522

[b]Disclaimer:[/b] http://bit.ly/OlN9DB

ACTCD

Nueva patente. Estos vienen a salir a patente cada quince días.

Pat Appl. No.: 14/138008
Methods for production of platelets from pluripotent stem cells and compositions thereof

Abstract

Methods for production of platelets from pluripotent stem cells, such as human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs) are provided. These methods may be performed without forming embryoid bodies or clusters of pluripotent stem cells, and may be performed without the use of stromal inducer cells. Additionally, the yield and/or purity can be greater than has been reported for prior methods of producing platelets from pluripotent stem cells. Also provided are compositions and pharmaceutical preparations comprising platelets, preferably produced from pluripotent stem cells.

DVAX
Se dispara 6% a final de sesión y en after con volumen sesion 5.1 M muy por encima de la media
Alguien sabe algo?